Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $1,588 | 73 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Novo Nordisk Inc | $460.21 | 10 | $0 (2024) |
| Lilly USA, LLC | $200.84 | 10 | $0 (2024) |
| ABBVIE INC. | $146.80 | 13 | $0 (2024) |
| Janssen Pharmaceuticals, Inc | $105.94 | 7 | $0 (2024) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $101.84 | 5 | $0 (2024) |
| PFIZER INC. | $95.37 | 4 | $0 (2024) |
| AstraZeneca Pharmaceuticals LP | $70.10 | 2 | $0 (2024) |
| Amgen Inc. | $58.86 | 4 | $0 (2024) |
| Dexcom, Inc. | $57.46 | 3 | $0 (2024) |
| Ultragenyx Pharmaceutical Inc. | $46.11 | 2 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $1,318 | 70 | Novo Nordisk Inc ($245.21) |
| 2020 | $102.60 | 1 | Novo Nordisk Inc ($102.60) |
| 2019 | $54.30 | 1 | AstraZeneca Pharmaceuticals LP ($54.30) |
| 2018 | $112.40 | 1 | Novo Nordisk Inc ($112.40) |
All Payment Transactions
73 individual payment records from CMS Open Payments — Page 1 of 3
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/26/2024 | Lilly USA, LLC | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $26.60 | General |
| Category: Diabetes | ||||||
| 12/26/2024 | Abbott Laboratories | PROCLAIM (Device) | Food and Beverage | In-kind items and services | $18.61 | General |
| Category: Neuromodulation | ||||||
| 12/05/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $22.90 | General |
| Category: Diabetes | ||||||
| 12/05/2024 | ABBVIE INC. | QULIPTA (Drug) | Food and Beverage | In-kind items and services | $5.32 | General |
| Category: NEUROSCIENCE | ||||||
| 12/05/2024 | ABBVIE INC. | QULIPTA (Drug) | Food and Beverage | In-kind items and services | $1.35 | General |
| Category: NEUROSCIENCE | ||||||
| 11/20/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $20.30 | General |
| Category: DIABETES | ||||||
| 11/15/2024 | ABBVIE INC. | QULIPTA (Drug) | Food and Beverage | In-kind items and services | $5.41 | General |
| Category: NEUROSCIENCE | ||||||
| 11/14/2024 | PFIZER INC. | ELIQUIS (Drug), NURTEC ODT | Food and Beverage | In-kind items and services | $17.04 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 11/12/2024 | IRONSHORE PHARMACEUTICALS INC. | JORNAY PM (Drug) | Food and Beverage | Cash or cash equivalent | $15.53 | General |
| Category: CENTRAL NERVOUS SYSTEM STIMULANT | ||||||
| 11/11/2024 | Lilly USA, LLC | MOUNJARO (Drug), ZEPBOUND | Food and Beverage | In-kind items and services | $17.98 | General |
| Category: Diabetes | ||||||
| 11/04/2024 | Hologic Sales and Service, LLC | APTIMA (Device) | Food and Beverage | In-kind items and services | $20.33 | General |
| Category: Diagnostics | ||||||
| 10/28/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $20.28 | General |
| Category: DIABETES | ||||||
| 10/23/2024 | Novo Nordisk Inc | Wegovy (Drug) | Food and Beverage | In-kind items and services | $101.32 | General |
| Category: Obesity | ||||||
| 10/23/2024 | ABBVIE INC. | QULIPTA (Drug) | Food and Beverage | In-kind items and services | $6.90 | General |
| Category: NEUROSCIENCE | ||||||
| 10/09/2024 | Dexcom, Inc. | Dexcom G6 Transmitter (Medical Supply) | Food and Beverage | In-kind items and services | $16.67 | General |
| Category: Endocrinology | ||||||
| 10/01/2024 | Lilly USA, LLC | — | Food and Beverage | In-kind items and services | $14.57 | General |
| 09/26/2024 | Lilly USA, LLC | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $24.64 | General |
| Category: Diabetes | ||||||
| 09/12/2024 | ABBVIE INC. | UBRELVY (Drug), QULIPTA | Food and Beverage | In-kind items and services | $9.86 | General |
| Category: NEUROSCIENCE | ||||||
| 09/06/2024 | Lilly USA, LLC | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $24.39 | General |
| Category: Diabetes | ||||||
| 09/05/2024 | Dexcom, Inc. | Dexcom G6 Transmitter (Medical Supply) | Food and Beverage | In-kind items and services | $17.70 | General |
| Category: Endocrinology | ||||||
| 08/30/2024 | Novo Nordisk Inc | Wegovy (Drug) | Food and Beverage | In-kind items and services | $18.24 | General |
| Category: Obesity | ||||||
| 08/23/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $24.05 | General |
| Category: Diabetes | ||||||
| 08/20/2024 | PFIZER INC. | ELIQUIS (Drug), NURTEC ODT | Food and Beverage | In-kind items and services | $28.09 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 08/16/2024 | Janssen Pharmaceuticals, Inc | SPRAVATO (Drug) | Food and Beverage | In-kind items and services | $13.13 | General |
| Category: Neuroscience | ||||||
| 08/14/2024 | Amgen Inc. | Otezla (Drug), Repatha | Food and Beverage | In-kind items and services | $15.55 | General |
| Category: Inflammation | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 4 | 224 | 335 | $71,081 | $23,739 |
| 2022 | 3 | 223 | 343 | $68,823 | $24,264 |
| 2021 | 3 | 238 | 411 | $78,851 | $28,162 |
| 2020 | 3 | 286 | 454 | $86,065 | $25,069 |
All Medicare Procedures & Services
13 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 119 | 229 | $47,861 | $12,867 | 26.9% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2023 | 67 | 67 | $14,673 | $8,280 | 56.4% |
| G0402 | Initial preventive physical examination; face-to-face visit, services limited to new beneficiary during the first 12 months of medicare enrollment | Office | 2023 | 11 | 11 | $4,301 | $1,381 | 32.1% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 27 | 28 | $4,246 | $1,210 | 28.5% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 117 | 229 | $47,861 | $14,265 | 29.8% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2022 | 62 | 62 | $13,578 | $7,841 | 57.7% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 44 | 52 | $7,384 | $2,159 | 29.2% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 106 | 238 | $49,742 | $15,470 | 31.1% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2021 | 59 | 59 | $12,921 | $7,609 | 58.9% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 73 | 114 | $16,188 | $5,084 | 31.4% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Office | 2020 | 112 | 235 | $49,115 | $11,868 | 24.2% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2020 | 76 | 76 | $16,644 | $8,569 | 51.5% |
| 99213 | Established patient office or other outpatient visit, typically 15 minutes | Office | 2020 | 98 | 143 | $20,306 | $4,633 | 22.8% |
About Dr. Jacinto Obregon, MD
Dr. Jacinto Obregon, MD is a Family Medicine healthcare provider based in Gatesville, Texas. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 08/07/2007. The National Provider Identifier (NPI) number assigned to this provider is 1396936019.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Jacinto Obregon, MD has received a total of $1,588 in payments from pharmaceutical and medical device companies, with $1,318 received in 2024. These payments were reported across 73 transactions from 19 companies. The most common payment nature is "Food and Beverage" ($1,588).
As a Medicare-enrolled provider, Obregon has provided services to 971 Medicare beneficiaries, totaling 1,543 services with total Medicare billing of $101,235. Data is available for 4 years (2020–2023), covering 13 distinct procedure/service records.
Practice Information
- Specialty Family Medicine
- Location Gatesville, TX
- Active Since 08/07/2007
- Last Updated 01/07/2021
- Taxonomy Code 207Q00000X
- Entity Type Individual
- NPI Number 1396936019
Products in Payments
- JARDIANCE (Drug) $228.76
- Ozempic (Drug) $210.36
- Wegovy (Drug) $137.45
- Victoza (Drug) $112.40
- SPRAVATO (Drug) $105.94
- QULIPTA (Drug) $98.16
- ELIQUIS (Drug) $95.37
- MOUNJARO (Drug) $59.35
- Otezla (Drug) $58.86
- Dexcom G6 Transmitter (Medical Supply) $57.46
- Crysvita (Drug) $46.11
- UBRELVY (Drug) $41.49
- Veozah (Drug) $39.75
- JORNAY PM (Drug) $36.90
- Kerendia (Drug) $33.23
- PROCLAIM (Device) $32.80
- VANTA ADAPTIVESTIM (Device) $30.94
- APTIMA (Device) $20.33
- VOQUEZNA (Drug) $18.10
- GARDASIL (Biological) $16.66
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Family Medicine Doctors in Gatesville
Dr. Diedra Wuenschel, D.o, D.O
Family Medicine — Payments: $5,523
Adrian Dirk, Md, MD
Family Medicine — Payments: $5,275
Zoe Walker, Md, MD
Family Medicine — Payments: $3,539
Dr. Timothy Maynard, M.d, M.D
Family Medicine — Payments: $2,080
Dr. Timothy Dannemiller, M.d, M.D
Family Medicine — Payments: $1,460
Dr. Charles Rismyhr, Md, MD
Family Medicine — Payments: $311.10